Castuner

CEConversations

Creative Educational Concepts

Welcome to CEConversations, a clinical podcast presented by Creative Educational Concepts designed to improve clinician performance and optimize patient outcomes.

Web do podcast

Escóitao na túa aplicación

Episodios

49 episodios

  1. Webcast Finding the Right Rhythm: Supporting Pediatric Oncology Nurses in Longitudinal NF1 Management 56:28
  2. Webcast: Rare, Complex, and Under-Recognized: Supporting Oncology Nurses in the Care of Patients with NF1 52:25
  3. A CaseWise™ Webcast: From Research to Real-World: ADCs, IO Combinations, and Sequencing in Metastatic NSCLC 1:07:45
  4. Exploring the Horizons in Advanced or Recurrent Endometrial Cancer: Practical Considerations and Future Directions for New Treatment Strategies 1:04:47
  5. Targeting the Pathway: Evolving Roles of MEK Inhibitors in NF1-Associated PN 1:04:25
  6. Evolving Paradigms in Immuno-Oncology: Optimizing Patient Care Through Innovative Delivery Approaches of Immune Checkpoint Inhibitors 32:12
  7. The New Era of Hemophilia Treatment 45:41
  8. MEK Inhibitors in Neurofibromatosis Type 1: Nursing Contributions to NF1-PN Management 1:04:33
  9. Desmoid Tumors in Focus: Early Recognition, Evolving Therapies, and Nursing-Led Care Strategies 54:51
  10. The MEKtrix: Decoding the Real-World Impact of Therapeutic Advances in Neurofibromatosis Type 1–Associated Plexiform Neurofibroma Management Across Pediatric and Adult Populations 1:32:45
  11. Emergency Care of Patients with Cancer Receiving CAR T-cell and Bispecific Antibody Immunotherapies Experiencing Serious Adverse Events 47:28
  12. Treating Metastatic HER2-negative Breast Cancer: Oncology Nursing Approaches to Improve Patient Quality of Life 49:37
  13. Advancing Cervical Cancer Care: Navigating New Therapies, Guidelines, and Patient-Centric Approaches 48:09
  14. MEK Inhibitors in Neurofibromatosis Type 1: Latest Advances and Real-World Applications in NF1-PN Management 1:03:44
  15. All Hands on Deck: Spotlight on Clinical Advances in Relapsed/Refractory Diffuse Large B-Cell Lymphoma 51:06
  16. Advancements in the Management of Relapsed/Refractory B-Cell Malignancies – Integrating Recent Data into Practice to Improve Outcomes 51:52
  17. All Hands on Deck: A Focus on Current and Emerging Treatment Options in the Frontline Setting for Peripheral T-cell Lymphoma 41:21
  18. All Hands on Deck in Cervical Cancer Care: Screening, Treatment, and Equity Strategies to Improve Patient Lives 1:00:36
  19. All Hands on Deck – Utilizing JAK Inhibitors in Myelofibrosis Care: Evidence, Timing, and Strategic Approaches 46:40
  20. Tailoring Patient Care Using Novel Agents in Metastatic Urothelial Carcinoma: Strategies for the Interprofessional Team 1:18:19
  21. Advancements and Applications of Antibody Drug Conjugates in HER2-Negative Breast Cancer 50:54
  22. Transforming Metastatic Breast Cancer Management: Harnessing the Power of Antibody-Drug Conjugate Therapies 1:33:21
  23. Navigating New Waters for Advanced or Recurrent Endometrial Cancer 1:06:48
  24. Cancer-Associated VTE: Balancing Risk and Reward with Modern Anticoagulation 50:27
  25. Actionable Strategies in Community Oncology to Achieve Equity in Triple-Negative Breast Cancer 54:13
  26. Primary Care Perspectives on Obesity: Embracing Novel Agents to Optimize Patient Outcomes 37:03
  27. Meeting Complex Challenges in Proteinuric Glomerular Disease: An Expert Review of Emerging Data and Novel Therapeutics for IgA Nephropathy 56:24
  28. Bridging Chasms in Bladder Cancer Care: An Expert Case-based Review of Treatment Selection and Sequencing in an Era of Therapeutic Novelty 1:30:56
  29. Nephrology Nursing Insights for Managing Chronic Kidney Disease–associated Pruritus: Embracing Evolving Data and Emerging Agents to Optimize Outcomes 41:04
  30. Navigating Novel Terrain in Anemia of Chronic Kidney Disease: A Patient-centric Review of Disease State, Current Chasms in Care, and the Future Promise of HIF-PH Inhibition 1:16:11
  31. Nephrology Nurse Viewpoints on In-hospital Hyperkalemia Management: Improving Patient Outcomes in Acute Care Settings with Novel Potassium Binders 57:39
  32. Harnessing the Power of Immunotherapy in HCC and BTC: An Expert Exploration of the Past, Present, and Future of Checkpoint Inhibition 1:02:45
  33. IV Iron Expert Exchange: Data-driven Debates on the Revolutionary Role of IV Iron in Heart Failure 1:36:50
  34. Pulmonology Perspectives on Biomarker Testing in NSCLC: Multidisciplinary Management in an Era of Rapid Change 1:47:28
  35. Optimizing Early Breast Cancer Outcomes in the Community Setting: An Expert Review of Emerging Therapies and Evolving Standards of Care in HR+/HER2- Disease 1:01:59
  36. Clinical Advances in Ovarian Cancer: Exploring the Expanding Role of PARP Inhibitors in the Treatment Paradigm 40:56
  37. Overcoming Pediatric Iron Deficiency Anemia with IV Iron: Interprofessional Approaches to Integrating New Data, Using Novel Agents, and Optimizing Care 53:32
  38. New Horizons in Unresectable Stage III NSCLC: A Case-based Exploration of Evolving Data and the Emergence of Immunotherapy 1:00:04
  39. Optimizing Cancer-related Anemia Outcomes in the Community Setting: Interprofessional Approaches and Evidence-supported Strategies for Improving Care with Intravenous Iron 49:32
  40. Breaking the Cycle in Cardiorenal Anemia Syndrome: The Practice-changing Role of IV Iron at the CKD–Heart Failure Interface 1:02:15
  41. 2022 EGFR+ Lung Cancer Rapid Recap: The Evolving State of the Science in EGFR+ NSCLC—A Closer Look at the Paradigm-Shifting Synergy of Safety, Efficacy, and Equitable Access 1:11:33
  42. Overcoming Disparity with Novelty in Triple-Negative Breast Cancer: Community Oncology Perspectives on Promoting Equity and Improving Clinical Outcomes 50:21
  43. Advancing Therapeutic Paradigms for Ovarian Cancer in The Era of PARP Inhibitors: A Guide for The Oncology Nurse 1:21:08
  44. Targeting Unmet Patient Needs in Diffuse Large B-Cell Lymphoma (DLBCL): Emerging Strategies for the Interprofessional Healthcare Team 47:17
  45. Interprofessional Perspectives on the Evolving Heart Failure Treatment Paradigm: Harnessing Novel Therapeutics to Optimize Outcomes & Overcome Disparities in Care 38:32
  46. Infusing Renewed Hope into Cancer-related Anemia with Intravenous Iron: An Expert-Led Exploration of Recent and Emerging Trial Data and Current Guideline Recommendations 46:27
  47. The Shot Heard 'Round the World: Vaccinating the Pandemic 33:32
  48. Restoring Normalcy via the Power of Immunology: Foundational Principles and Practical Questions 35:20
  49. COVID-19: What We Know About the Virus & the Disease 34:16